Aflibercept a 'Powerful' Tool in Treatment of Diabetic Macular Edema: Charles Wykoff, Retina Consultants Houston

Video

The treatment of diabetic retinopathy, particularly diabetic macular edema has come a long way over the past decade, especially since the approval of aflibrecept to treat these patients.

The treatment of diabetic retinopathy, particularly diabetic macular edema has come a long way over the past decade, especially since the approval of aflibercept to treat these patients.

Charles C. Wykoff, MD, PhD, from Retina Consultants Houstan, discussed this topic during the annual meeting of the American Academy of Ophthalmology in Chicago. Wykoff said because of the damage diabetes can do to a patient's eyes treating it correctly can make a considerable difference in the life of a patient.

Related Videos
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Veraprapas Kittipibul, MD | Credit: X.com
Peter A. Campochiaro, MD: RGX-314 for nAMD | Image Credit: Johns Hopkins Medicine
© 2024 MJH Life Sciences

All rights reserved.